387 related articles for article (PubMed ID: 25303478)
1. Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis.
Feldman SR; Zhao Y; Shi L; Tran MH; Lu J
Arthritis Care Res (Hoboken); 2015 May; 67(5):708-17. PubMed ID: 25303478
[TBL] [Abstract][Full Text] [Related]
2. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis.
Feldman SR; Zhao Y; Shi L; Tran MH
J Manag Care Spec Pharm; 2015 Oct; 21(10):874-88. PubMed ID: 26402388
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population.
Lee S; Xie L; Wang Y; Vaidya N; Baser O
J Med Econ; 2018 Jun; 21(6):564-570. PubMed ID: 29359606
[TBL] [Abstract][Full Text] [Related]
4. Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA.
Merola JF; Herrera V; Palmer JB
Clin Rheumatol; 2018 Oct; 37(10):2751-2761. PubMed ID: 30051284
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis.
Placzek H; Xu Y; Mu Y; Begelman SM; Fisher M
J Manag Care Spec Pharm; 2015 Dec; 21(12):1106-12. PubMed ID: 26679960
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense Population.
Lee S; Xie L; Wang Y; Vaidya N; Baser O
J Manag Care Spec Pharm; 2018 Jul; 24(7):654-663. PubMed ID: 29952710
[TBL] [Abstract][Full Text] [Related]
7. Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis.
Skornicki M; Prince P; Suruki R; Lee E; Louder A
Adv Ther; 2021 May; 38(5):2458-2471. PubMed ID: 33818686
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
9. Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using U.S. Administrative Claims Data.
Kaine J; Song X; Kim G; Hur P; Palmer JB
J Manag Care Spec Pharm; 2019 Jan; 25(1):122-132. PubMed ID: 29694270
[TBL] [Abstract][Full Text] [Related]
10. Healthcare Resource Use and Direct Costs in Patients with Ankylosing Spondylitis and Psoriatic Arthritis in a Large US Cohort.
Greenberg JD; Palmer JB; Li Y; Herrera V; Tsang Y; Liao M
J Rheumatol; 2016 Jan; 43(1):88-96. PubMed ID: 26628601
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of joint analysis in psoriasis: US claims analysis.
Prince P; Skornicki M; Suruki R; Lee E; Louder A
Am J Manag Care; 2021 Dec; 27(12):e406-e412. PubMed ID: 34889582
[TBL] [Abstract][Full Text] [Related]
12. Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States.
Hopson S; Gibbs LR; Syed S; Low R; McClung L; Beaty S
Adv Ther; 2023 Oct; 40(10):4358-4376. PubMed ID: 37486558
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database.
Feldman SR; Tian H; Gilloteau I; Mollon P; Shu M
BMC Health Serv Res; 2017 May; 17(1):337. PubMed ID: 28482887
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study.
Grellmann C; Dombrowsky W; Fabricius V; Suruki R; Sheahan A; Joeres L
Adv Ther; 2021 Jan; 38(1):366-385. PubMed ID: 33128201
[TBL] [Abstract][Full Text] [Related]
15. Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis in the USA-a retrospective study of claims data from 2009 to 2020.
Merola JF; Dennis N; Chakravarty SD; Villacorta R; Mesana L; Lin I; Wang Y; Shawi M; Pacou M; Baker T; Peterson S
Clin Rheumatol; 2021 Oct; 40(10):4061-4070. PubMed ID: 33934270
[TBL] [Abstract][Full Text] [Related]
16. Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.
Al Sawah S; Foster SA; Goldblum OM; Malatestinic WN; Zhu B; Shi N; Song X; Feldman SR
J Med Econ; 2017 Sep; 20(9):982-990. PubMed ID: 28635342
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United States.
Merola JF; Tian H; Patil D; Richardson C; Scott A; Chen YH; Kim N; Hur P; Armstrong AW
J Am Acad Dermatol; 2022 Apr; 86(4):748-757. PubMed ID: 34547358
[TBL] [Abstract][Full Text] [Related]
18. Incremental Costs for Psoriasis and Psoriatic Arthritis in a Population-based Cohort in Southern Sweden: Is It All Psoriasis-attributable Morbidity?
Löfvendahl S; Petersson IF; Theander E; Svensson Å; Zhou C; Steen Carlsson K
J Rheumatol; 2016 Mar; 43(3):640-7. PubMed ID: 26773111
[TBL] [Abstract][Full Text] [Related]
19. Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis.
Nas K; Karkucak M; Durmus B; Karatay S; Capkın E; Kaya A; Ucmak D; Akar ZA; Cevik R; Kilic E; Kilic G; Ozgocmen S
Int J Rheum Dis; 2015 Nov; 18(8):873-9. PubMed ID: 26173043
[TBL] [Abstract][Full Text] [Related]
20. Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis.
Wu JJ; Pelletier C; Ung B; Tian M; Khilfeh I; Curtis JR
Adv Ther; 2020 May; 37(5):2098-2115. PubMed ID: 32141018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
